DIRS.INFO The most relevant business & tech news

☆ These stocks were analysts' top picks for 2024. How they are doing nearly 3 months in
▼ + stars: | 2024-02-27 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

Now, we're tracking how well the analysts' picks have performed just three months into the new year. About 93% of analysts surveyed by LSEG hold a buy rating on Nvidia and have an average price target of $832.52. Warner Bros. Shares of Warner Bros. are down nearly 25% in the new year, and have lost about 45% over the past 12 months. Further, Warner Bros. did not give free cash flow guidance for 2024.

Persons: drugmaker Viatris, David Einhorn, Einhorn, Max Organizations: Dow Jones Industrial, CNBC, Nvidia, drugmaker, Pfizer, Warner Bros, APA Corp, Halliburton, Caesars Entertainment Locations: LSEG

☆ Goldman says these types of dividend stocks are the best to own in wake of big Meta payout news
▼ + stars: | 2024-02-12 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

For investors, that suggests opportunity in certain dividend stocks, Kostin wrote. Since late 2022, Goldman Sachs' Dividend Yield and Growth basket (GSTHDIVG), a 50-stock, equal-weighted basket of stocks with high trailing dividend yield and high anticipated dividend growth, has outperformed the equal-weighted S & P 500 by 3 percentage points. As of October, here are some of the stocks in the firm's dividend yield and growth basket. Verizon Communications Communication services stock Verizon Communications is a constituent in the dividend growth basket. Other stocks in Goldman's dividend growth basket include Best Buy , Conagra Brands and Devon Energy .

Persons: Goldman Sachs, David J, Meta, Kostin, That's, Greenlight Capital's David Einhorn, Morgan Stanley, Simon Flannery, — CNBC's Michael Bloom Organizations: Facebook, Bank of America, Federal Reserve, Verizon Communications Communication, Verizon Communications, Verizon, Conagra Brands, Devon Energy Locations: Viatris

☆ Greenlight’s David Einhorn ends his buyers' strike, finds a few 'promising' new stocks
▼ + stars: | 2024-01-22 | by ( Yun Li | ) www.cnbc.com time to read: +3 min

"We ended our buyers' strike and found several promising new investments that we believe will help us in 2024," the hedge fund manager said in an investor letter dated Monday and obtained by CNBC. Einhorn had stopped building new stock positions at one point in the fourth quarter due to worries about intensifying geopolitical risks. Because of his conservative positioning, his hedge fund, particularly the short side, was hurt during 2023's strong year-end rally. Einhorn's hedge fund returned 22.1% in 2023, net of fees and expenses. His stellar track record made him one of the most followed hedge fund managers on Wall Street.

Persons: Capital's David Einhorn, Einhorn, he's, Greenlight, drugmaker, He's, CNBC's Leslie Picker Organizations: CNBC, Cornell grad, Greenlight Capital, Wall, Pfizer, Syensqo, U.S . Aerospace & Defense, Invesco Aerospace & Defense, P Aerospace & Defense Locations: Belgian, U.S

LONDON, March 2 (Reuters) - Drugmaker Viatris Inc (VTRS.O) warned on Thursday that it will stop selling some essential medicines in the UK that are already in short supply unless the British government makes changes to its voluntary medicines pricing agreement. If that level is exceeded, the government recoups the excess from suppliers of branded drugs. His colleague Viatris' Head of Europe Artur Cwiok named Germany and Portugal as countries where governments were weighing changes to drug pricing. If Viatris opted to leave that pricing scheme, it would have to pay a rate in the statutory scheme the government says will rise to 27.5%. Pharma companies AbbVie Inc (ABBV.N) and Eli Lilly and Co (LLY.N) withdrew from the pricing scheme in January.

Search resuls for: "drugmaker Viatris"

4 mentions found